Nomura Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Sell
1,500
-29,100
-95% -$29.5M ﹤0.01% 1047
2025
Q4
$32.9M Buy
30,600
+24,100
+371% +$23M 0.04% 218
2025
Q3
$4.96M Sell
6,500
-16,100
-71% -$12M 0.01% 782
2025
Q2
$17.6M Sell
22,600
-18,300
-45% -$14.2M 0.04% 278
2025
Q1
$33.8M Buy
40,900
+40,600
+13,533% +$33.8M 0.06% 201
2024
Q4
$232K Sell
300
-25,300
-99% -$20.9M ﹤0.01% 2023
2024
Q3
$22.7M Buy
+25,600
New +$23M 0.05% 234
2024
Q2
Sell
-18,200
Closed -$14.2M 1906
2024
Q1
$14.2M Sell
18,200
-2,700
-13% -$1.92M 0.04% 348
2023
Q4
$12.2M Sell
20,900
-25,000
-54% -$14.6M 0.03% 391
2023
Q3
$24.7M Sell
45,900
-54,100
-54% -$27.9M 0.07% 188
2023
Q2
$46.9M Buy
100,000
+85,600
+594% +$35.9M 0.13% 130
2023
Q1
$4.95M Sell
14,400
-5,700
-28% -$1.92M 0.02% 552
2022
Q4
$7.35M Buy
+20,100
New +$7.13M 0.03% 391
2022
Q1
Sell
-50,000
Closed -$13.8M 2226
2021
Q4
$13.8M Buy
+50,000
New +$12.7M 0.04% 371
2019
Q2
Sell
-1,750,600
Closed -$226M 1239
2019
Q1
$226M Buy
+1,750,600
New +$213M 0.95% 14
2018
Q2
Sell
-100,000
Closed -$7.74K 1439
2018
Q1
$7.74K Buy
+100,000
New +$8.05M 0.01% 461
2017
Q1
Sell
-393,700
Closed -$29M 1467
2016
Q4
$29M Buy
393,700
+74,200
+23% +$5.53M 0.07% 161
2016
Q3
$25.6M Buy
+319,500
New +$25.6M 0.07% 144
2015
Q1
Sell
-61,800
Closed -$4.22M 2049
2014
Q4
$4.22M Sell
61,800
-24,500
-28% -$1.65M 0.01% 673
2014
Q3
$5.57M Buy
86,300
+48,800
+130% +$3.09M 0.02% 650
2014
Q2
$2.33M Hold
37,500
﹤0.01% 1049
2014
Q1
$2.2M Buy
+37,500
New +$2.09M ﹤0.01% 1128

Other funds holding LLY

Nomura Holdings's LLY Position: Q1 2026 in Review

Nomura Holdings increased its Eli Lilly (LLY) stake by 167% in Q1 2026, buying an estimated $11M and bringing the position to 17,421 shares worth $16M. The position accounts for 0.04% of the portfolio, ranked #307.

Nomura Holdings first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $85.8M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Nomura Holdings held 17,421 shares of Eli Lilly worth $16M as of Q1 2026.
  • Nomura Holdings bought 10,885 Eli Lilly shares in Q1 2026, an estimated $11M.
  • Eli Lilly made up 0.04% of Nomura Holdings's portfolio in Q1 2026, its #307 holding.
  • Nomura Holdings first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
  • Nomura Holdings's Eli Lilly position peaked at $85.8M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.